Andrew Callos
Corporate Officer/Principal presso CYTOKINETICS, INCORPORATED
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Mr. Andrew Callos is a Chief Commercial Officer & Executive VP at Cytokinetics, Inc. Mr. Callos was previously employed as a Vice President-US Cardiology & Metabolic Marketing by Pfizer Inc. and an Assistant Vice President-Marketing by Wyeth Pharmaceuticals, Inc. He received his undergraduate degree from Drexel University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 14/03/2024 | 63 887 ( 0.06% ) | 4 M $ | 31/03/2024 |
Posizioni attive di Andrew Callos
| Società | Posizione | Inizio |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/03/2021 |
Precedenti posizioni note di Andrew Callos
| Società | Posizione | Fine |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Sales & Marketing | - |
Formazione di Andrew Callos
| Drexel University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| Aziende private | 1 |
|---|---|
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
- Borsa valori
- Insiders
- Andrew Callos
